Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Sonnet BioTherapeutics Holdings, Inc. SONN

Set alert

Price alert · SONN

All alert types
1.26 0.00 0.00%

At close · Dec 2

1.26 Day range 3.23
1.42 52-week range 18.72
YTD
-13.70%
1 year
-51.72%
Open
3.16
Prev close
1.26
Mkt cap
4.33M
Vol
10.43M
Avg vol
1.33M
EPS
-11.35
P/E
0.00
Div yield
0.00%
More statistics
Low
1.26
High
3.23
Forward P/E
-0.10
Beta
1.04
Short ratio
0.03
Inst. own
0.20%
Dividend
0.00
Ex-div date
Earnings
Feb 12, 2025
50-d avg
3.46
200-d avg
8.63
1y target
160.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SONN has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-10.45 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.2×
FY 2016: -2.0×FY 2017: -1.9×FY 2018: -1.3×FY 2019: -0.6×FY 2020: -0.7×FY 2021: -0.6×FY 2022: -0.2×FY 2023: -0.2×FY 2024: -0.6×FY 2025: -1.2×
FY 2016 5y median -0.6× FY 2025
P/S 18.7×
FY 2016: 0.4×FY 2017: 0.3×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.0×FY 2021: 30.7×FY 2022: 18.2×FY 2023: 20.1×FY 2024: 235×FY 2025: 18.7×
FY 2016 5y median 20.1× FY 2025
P/B 1.7×
FY 2016: 1.4×FY 2017: 1.2×FY 2018: 1.2×FY 2019: -3.5×FY 2020: 16.0×FY 2021: 0.7×FY 2022: -2.5×FY 2023: -13.2×FY 2024: -9.0×FY 2025: 1.7×
FY 2016 5y median -2.5× FY 2025
P/FCF -1.5×
FY 2016: -10.8×FY 2017: -5.6×FY 2018: -3.2×FY 2019: -2.2×FY 2020: -3.1×FY 2021: -0.7×FY 2022: -0.2×FY 2023: -0.1×FY 2024: -0.5×FY 2025: -1.5×
FY 2016 5y median -0.5× FY 2025
EV/EBITDA 153×
FY 2016: 52.4×FY 2017: -7.6×FY 2018: -5.1×FY 2019: -0.8×FY 2020: -1.7×FY 2021: 0.5×FY 2022: -0.1×FY 2023: -0.0×FY 2024: -0.4×FY 2025: 153×
FY 2016 5y median -0.0× FY 2025
EV/Sales 13.6×
FY 2016: 0.7×FY 2017: 0.5×FY 2018: 0.6×FY 2019: 0.3×FY 2020: 0.0×FY 2021: -26.1×FY 2022: 10.3×FY 2023: 6.1×FY 2024: 234×FY 2025: 13.6×
FY 2016 5y median 10.3× FY 2025
FCF Yield -68.6%
FY 2016: -9.3%FY 2017: -17.9%FY 2018: -31.0%FY 2019: -45.9%FY 2020: -32.4%FY 2021: -151.8%FY 2022: -447.7%FY 2023: -732.4%FY 2024: -196.4%FY 2025: -68.6%
FY 2016 5y median -196.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 8.0%FY 2017: 4.9%FY 2018: 2.6%FY 2019: 80.5%FY 2020: 0.0%FY 2021: 100.0%FY 2022: -6027.9%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 0.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -1584.4%
FY 2016: -6.3%FY 2017: -6.1%FY 2018: -10.0%FY 2019: -11.6%FY 2020: 0.0%FY 2021: -5187.4%FY 2022: -8478.3%FY 2023: -12714.5%FY 2024: -63617.9%FY 2025: -1584.4%
FY 2016 5y median -8478.3% FY 2025
Net Margin -1611.3%
FY 2016: -21.8%FY 2017: -16.4%FY 2018: -22.3%FY 2019: -12.0%FY 2020: 0.0%FY 2021: -5170.5%FY 2022: -8508.3%FY 2023: -12741.6%FY 2024: -39929.3%FY 2025: -1611.3%
FY 2016 5y median -8508.3% FY 2025
ROE -149.4%
FY 2016: -70.8%FY 2017: -63.5%FY 2018: -92.2%FY 2019: 171.2%FY 2020: -803.5%FY 2021: -112.3%FY 2022: 1172.8%FY 2023: 8333.8%FY 2024: 1531.1%FY 2025: -149.4%
FY 2016 5y median 1172.8% FY 2025
ROIC -144.2%
FY 2016: -9.4%FY 2017: -9.6%FY 2018: -10.8%FY 2019: -18.5%FY 2020: -516.2%FY 2021: -112.1%FY 2022: 1299.7%FY 2023: 85153.9%FY 2024: 3339.1%FY 2025: -144.2%
FY 2016 5y median 1299.7% FY 2025
ROA -108.3%
FY 2016: -27.1%FY 2017: -22.5%FY 2018: -23.0%FY 2019: -12253.4%FY 2020: -303.5%FY 2021: -86.2%FY 2022: -510.7%FY 2023: -346.9%FY 2024: -268.4%FY 2025: -108.3%
FY 2016 5y median -268.4% FY 2025

Growth (YoY)

Revenue 5268.8%
FY 2016: -1.6%FY 2017: -0.6%FY 2018: -25.8%FY 2019: 32.1%FY 2020: -100.0%FY 2021: 0.0%FY 2022: -27.6%FY 2023: -57.8%FY 2024: -87.4%FY 2025: 5268.8%
FY 2016 FY 2025
Operating Income -33.7%
FY 2016: 77.2%FY 2017: 3.8%FY 2018: -21.8%FY 2019: -53.3%FY 2020: -269.8%FY 2021: -44.1%FY 2022: -18.3%FY 2023: 36.7%FY 2024: 36.9%FY 2025: -33.7%
FY 2016 FY 2025
EPS (diluted) 65.2%
FY 2016: 50.6%FY 2017: 34.9%FY 2018: 27.5%FY 2019: -29.0%FY 2020: 89.5%FY 2021: 85.4%FY 2022: 52.0%FY 2023: 87.9%FY 2024: 92.2%FY 2025: 65.2%
FY 2016 FY 2025
Free Cash Flow -49.0%
FY 2016: 76.3%FY 2017: -38.2%FY 2018: -19.5%FY 2019: -64.5%FY 2020: -239.7%FY 2021: -43.8%FY 2022: -26.7%FY 2023: 23.8%FY 2024: 60.5%FY 2025: -49.0%
FY 2016 FY 2025

Financial Health

Current Ratio 3.5×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.0×FY 2020: 1.6×FY 2021: 4.3×FY 2022: 0.7×FY 2023: 0.9×FY 2024: 0.7×FY 2025: 3.5×
FY 2016 5y median 0.9× FY 2025
Quick Ratio 3.5×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.1×FY 2019: -0.1×FY 2020: 1.6×FY 2021: 4.3×FY 2022: 0.7×FY 2023: 0.9×FY 2024: 0.7×FY 2025: 3.5×
FY 2016 5y median 0.9× FY 2025
Debt / Equity 0.0×
FY 2016: 0.8×FY 2017: 0.9×FY 2018: 1.4×FY 2019: -0.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: -0.1×FY 2023: -0.9×FY 2024: -0.3×FY 2025: 0.0×
FY 2016 5y median -0.1× FY 2025
Net Debt / EBITDA -56.8×
FY 2016: 18.6×FY 2017: -3.1×FY 2018: -2.6×FY 2019: -0.0×FY 2020: 0.3×FY 2021: 1.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.0×FY 2025: -56.8×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016: 1.1×FY 2017: 1.0×FY 2018: -8.0×FY 2019: -28.9×FY 2020: -842×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30